BECN1 and neoplasm: Tumor-derived lactate promotes the transcription of RUBCNL/Pacer through H3K18la and promotes the maturation of autophagosomes by interacting with BECN1 (beclin 1), thus promoting the resistance of colorectal cancer to bevacizumab [112].